OXISTAT- oxiconazole nitrate lotion মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

oxistat- oxiconazole nitrate lotion

rebel distributors corp. - oxiconazole nitrate (unii: rq8ul4c17s) (oxiconazole - unii:c668q9i33j) - oxiconazole nitrate 30 mg in 1 g - oxistat® cream and lotion are indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to trichophyton rubrum, trichophyton mentagrophytes, or epidermophyton floccosum. oxistat® cream is indicated for the topical treatment of tinea (pityriasis) versicolor due to malassezia furfur (see dosage and administration and clinical studies). oxistat® cream may be used in pediatric patients for tinea corporis, tinea cruris, tinea pedis, and tinea (pityriasis) versicolor; however, these indications for which oxistat® cream has been shown to be effective rarely occur in children below the age of 12. oxistat® cream and lotion are contraindicated in individuals who have shown hypersensitivity to any of their components.

KALETRA- lopinavir and ritonavir tablet, film coated মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

kaletra- lopinavir and ritonavir tablet, film coated

rebel distributors corp - lopinavir (unii: 2494g1jf75) (lopinavir - unii:2494g1jf75), ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825) - lopinavir 200 mg - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection. the following points should be considered when initiating therapy with kaletra: - the use of other active agents with kaletra is associated with a greater likelihood of treatment response [see clinical pharmacology (12.4) and clinical studies (14)] . - genotypic or phenotypic testing and/or treatment history should guide the use of kaletra [see clinical pharmacology (12.4)] . the number of baseline lopinavir resistance-associated substitutions affects the virologic response to kaletra [see clinical pharmacology (12.4)] . - once daily administration of kaletra is not recommended for any pediatric patients. ● kaletra is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., toxic epidermal necrolysis, stevens-johnson syndrome, erythema multiforme) to any of its ingredients, including ritonavir. ●  co-administration of kaletra is contraindicated with drugs th

RISPERIDONE tablet মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

risperidone tablet

rebel distributors corp - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 1 mg - adults risperidone tablets are indicated for the acute and maintenance treatment of schizophrenia [see clinical studies (14.1)]. adolescents due to janssen pharmaceuticals corporation’s marketing exclusivity rights, this drug product is not labeled for use in pediatric patients with schizophrenia .pediatric use information for the treatment of pediatric patients with schizophrenia, 13 to 17 years of age, is approved for janssen pharmaceuticals corporation’s risperidone drug products. monotherapy - adults and pediatrics risperidone is indicated for the short-term treatment of acute manic or mixed episodes associated with bipolar i disorder in adults [see clinical studies (14.2)]. due to janssen pharmaceuticals corporation’s marketing exclusivity rights, this drug product is not labeled for use in pediatric patients with bipolar mania. pediatric use information for the treatment of pediatric patients with bipolar mania, 10 to 17 years of age, is approved for janssen pharmaceuticals corporation’s risperidone dru

SINGULAIR- montelukast sodium tablet, chewable
SINGULAIR- montelukast sodium tablet, film coated মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

singulair- montelukast sodium tablet, chewable singulair- montelukast sodium tablet, film coated

rebel distributors corp - montelukast sodium (unii: u1o3j18sfl) (montelukast - unii:mhm278sd3e) - montelukast 5 mg - singulair1 is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. registered trademark of merck sharp & dohme corp., a subsidiary of merck & co., inc. copyright © 1998-2010 merck sharp & dohme corp., a subsidiary of merck & co., inc. all rights reserved singulair is indicated for prevention of exercise-induced bronchoconstriction (eib) in patients 15 years of age and older. singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older. hypersensitivity to any component of this product. pregnancy category b: there are no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, singulair should be used during pregnancy only if clearly needed. teratogenic effect: no teratogenicity was observed in rats and rabbits at doses approximate

WARFARIN SODIUM tablet মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

warfarin sodium tablet

rebel distributors corp - warfarin sodium (unii: 6153cwm0cl) (warfarin - unii:5q7zvv76ei) - warfarin sodium 1 mg - warfarin sodium tablets are indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. warfarin sodium tablets are indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. warfarin sodium tablets are indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction. anticoagulation is contraindicated in any localized or general physical condition or personal circumstance in which the hazard of hemorrhage might be greater than the potential clinical benefits of anticoagulation, such as: warfarin sodium tablets are contraindicated in women who are or may become pregnant because the drug passes through the placental barrier and may cause fatal hemorrhage to the fetus in utero. furthermore, there have been reports of birth malformations in children born to mothers who

WELLBUTRIN XL- bupropion hydrochloride tablet, extended release মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

wellbutrin xl- bupropion hydrochloride tablet, extended release

rebel distributors corp - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion 150 mg - major depressive disorder: wellbutrin xl is indicated for the treatment of major depressive disorder. the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled trials of inpatients and in one 6-week controlled trial of outpatients whose diagnoses corresponded most closely to the major depression category of the apa diagnostic and statistical manual (dsm) (see clinical trials ). a major depressive episode (dsm-iv) implies the presence of 1) depressed mood or 2) loss of interest or pleasure; in addition, at least 5 of the following symptoms have been present during the same 2-week period and represent a change from previous functioning: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt, or suicidal ideatio

AMIODARONE HYDROCHLORIDE tablet মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

amiodarone hydrochloride tablet

rebel distributors corp - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 200 mg - because of its life-threatening side effects and the substantial management difficulties associated with its use (see warnings below), amiodarone is indicated only for the treatment of the following documented, life-threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated. - recurrent ventricular fibrillation. - recurrent hemodynamically unstable ventricular tachycardia. as is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of amiodarone hydrochloride tablets favorably affects survival. amiodarone should be used only by physicians familiar with and with access to (directly or through referral) the use of all available modalities for treating recurrent life-threatening ventricular arrhythmias, and who have access to appropriate monitoring facilities, including in-hospital and ambulatory continuous electrocardiographic monitoring

LEVETIRACETAM tablet মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

levetiracetam tablet

rebel distributors corp - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 500 mg - levetiracetam tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy. this product should not be administered to patients who have previously exhibited hypersensitivity to levetiracetam or any of the inactive ingredients in levetiracetam tablets. the abuse and dependence potential of levetiracetam has not been evaluated in human studies.

PIROXICAM capsule মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

piroxicam capsule

rebel distributors corp - piroxicam (unii: 13t4o6vmam) (piroxicam - unii:13t4o6vmam) - piroxicam 10 mg - carefully consider the potential benefits and risks of piroxicam capsules usp and other treatment options before deciding to use piroxicam capsules usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). piroxicam capsules usp is indicated: - for relief of the signs and symptoms of osteoarthritis. - for relief of the signs and symptoms of rheumatoid arthritis. piroxicam capsules usp is contraindicated in patients with known hypersensitivity to piroxicam. piroxicam capsules usp should not be given to patients who have experienced asthma, urticaria or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings: anaphylactoid reactions and precautions: preexisting asthma ). piroxicam capsules usp is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings

NAPROXEN tablet মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

naproxen tablet

rebel distributors corp - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen 375 mg - carefully consider the potential benefits and risks of naproxen, naproxen sodium and other treatment options before deciding to use naproxen and naproxen sodium tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naproxen as naproxen or naproxen sodium tablets are indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis naproxen as naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient’s weight. naproxen as naproxen and naproxen sodium tablets are also indicated: - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms of acute gout - for the managem